Literature DB >> 18505185

Differences in susceptibility to Haemophilus parasuis infection in pigs.

Isabel Blanco1, Ana Canals, Gary Evans, Martha A Mellencamp, Carmen Cia, Nader Deeb, Lizhen Wang, Lucina Galina-Pantoja.   

Abstract

In animal breeding programs, deoxyribonucleic acid (DNA) markers can be used to identify sires that are less susceptible to disease. These DNA markers are typically discovered in populations that display differences in susceptibility. To find those differences, it was hypothesized that sires influence their offspring responses to infection with H. parasuis. To identify differences in susceptibility, colostrum-deprived pigs derived from 6 sires were inoculated with a virulent strain of H. parasuis serovar 5. Pigs were infected at 21-d of age and euthanized 1, 2, or 3 days post-infection. Rectal temperatures, bacterial detection, clinical signs, and lesions were measured by comparing disease susceptibility in the offspring from each sire. The effect of the sire on the severity of disease in the offspring was statistically analyzed using to a 2-way ANOVA with sire and test day as fixed effects. Significant differences among sires were found for lesions, rectal temperatures from days 0-1 and 0-2 (P < 0.05) and marginal effects for clinical signs (P = 0.08). On average, the offspring of sire H94 was the most susceptible to challenge. Responses to infection were categorized to determine the clinical responses and analyzed by Chi square. Overall, 10% of all pigs infected were fully resistant to H. parasuis infection. Boar H94 didn't produce any fully resistant offspring. Differences in susceptibility to H. parasuis were observed, and the results support the hypothesis that sires influence their offspring's response to infection. Tissues from this population could be used to identify DNA markers for genetic selection of sires that produce offspring more resistant to H. parasuis infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18505185      PMCID: PMC2327248     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  27 in total

1.  Escherichia coli diarrhoea in pigs with or without the K88 receptor.

Authors:  R Sellwood
Journal:  Vet Rec       Date:  1979-09-08       Impact factor: 2.695

2.  Development of a PCR test to diagnose Haemophilus parasuis infections.

Authors:  S Oliveira; L Galina; C Pijoan
Journal:  J Vet Diagn Invest       Date:  2001-11       Impact factor: 1.279

3.  A DNA polymorphism influencing alpha(1,2)fucosyltransferase activity of the pig FUT1 enzyme determines susceptibility of small intestinal epithelium to Escherichia coli F18 adhesion.

Authors:  E Meijerink; S Neuenschwander; R Fries; A Dinter; H U Bertschinger; G Stranzinger; P Vögeli
Journal:  Immunogenetics       Date:  2000-11       Impact factor: 2.846

4.  Haemophilus parasuis invades porcine brain microvascular endothelial cells.

Authors:  Ghyslaine Vanier; Anna Szczotka; Peter Friedl; Sonia Lacouture; Mario Jacques; Marcelo Gottschalk
Journal:  Microbiology (Reading)       Date:  2006-01       Impact factor: 2.777

5.  Postweaning multisystemic wasting syndrome of pigs in Korea: prevalence, microscopic lesions and coexisting microorganisms.

Authors:  Junghyun Kim; Han-Kook Chung; Taewon Jung; Wan-Seob Cho; Changsun Choi; Chanhee Chae
Journal:  J Vet Med Sci       Date:  2002-01       Impact factor: 1.267

6.  Association between the porcine Escherichia coli F18 receptor genotype and phenotype and susceptibility to colonisation and postweaning diarrhoea caused by E. coli O138:F18.

Authors:  Kai Frydendahl; Tim Kåre Jensen; Jens Strodl Andersen; Merete Fredholm; Gary Evans
Journal:  Vet Microbiol       Date:  2003-05-02       Impact factor: 3.293

7.  Characterisation of a resource population of pigs screened for resistance to salmonellosis.

Authors:  P M van Diemen; M B Kreukniet; L Galina; N Bumstead; T S Wallis
Journal:  Vet Immunol Immunopathol       Date:  2002-09-25       Impact factor: 2.046

8.  Comparison between Haemophilus parasuis infection in colostrums-deprived and sow-reared piglets.

Authors:  I Blanco; L Galina-Pantoja; S Oliveira; C Pijoan; C Sánchez; A Canals
Journal:  Vet Microbiol       Date:  2004-10-05       Impact factor: 3.293

9.  Naturally-farrowed, artificially-reared pigs as an alternative model for experimental infection by Haemophilus parasuis.

Authors:  Simone Oliveira; Lucina Galina; Isabel Blanco; Ana Canals; Carlos Pijoan
Journal:  Can J Vet Res       Date:  2003-05       Impact factor: 1.310

Review 10.  Haemophilus parasuis: new trends on diagnosis, epidemiology and control.

Authors:  Simone Oliveira; Carlos Pijoan
Journal:  Vet Microbiol       Date:  2004-03-26       Impact factor: 3.293

View more
  4 in total

1.  Development and characterization of protective Haemophilus parasuis subunit vaccines based on native proteins with affinity to porcine transferrin and comparison with other subunit and commercial vaccines.

Authors:  Rafael Frandoloso; Sonia Martínez; Elías F Rodríguez-Ferri; María José García-Iglesias; Claudia Pérez-Martínez; Beatriz Martínez-Fernández; César B Gutiérrez-Martín
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

2.  The live attenuated Actinobacillus pleuropneumoniae triple-deletion mutant ΔapxIC ΔapxIIC ΔapxIV-ORF1 strain, SLW05, Immunizes pigs against lethal challenge with Haemophilus parasuis.

Authors:  Shulin Fu; Jiwen Ou; Minmin Zhang; Juan Xu; Huazhen Liu; Jinlin Liu; Fangyan Yuan; Huanchun Chen; Weicheng Bei
Journal:  Clin Vaccine Immunol       Date:  2012-12-05

3.  Gene expression profiling in the lungs of pigs with different susceptibilities to Glässer's disease.

Authors:  Jamie M Wilkinson; Carole A Sargent; Lucina Galina-Pantoja; Alexander W Tucker
Journal:  BMC Genomics       Date:  2010-07-29       Impact factor: 3.969

4.  Immunogenomics for identification of disease resistance genes in pigs: a review focusing on Gram-negative bacilli.

Authors:  Shuhong Zhao; Mengjin Zhu; Hongbo Chen
Journal:  J Anim Sci Biotechnol       Date:  2012-11-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.